OSUR (OraSure Technologies Inc) Market Value to Book Value Ratio

OraSure (OSUR) - corporate logo

OraSure Technologies (OSUR) specializes in the diagnostic testing of biomaterials. This chart illustrates the price action of the asset, which currently stands at 0.89. The business relies on an impeccable reputation for developing accurate rapid home tests. Stability is ensured by automated reagent production plants operating at full capacity without technical failures. The company's environmental development strategy focuses on minimizing plastic waste through packaging recycling.

OSUR - OraSure Corp Market-to-Book Ratio over the range 07/04/2022 - 10/28/2026
Flagship merchandise of OraSure Technologies Inc

This ratio compares the market value of OraSure Technologies (OSUR) to its net assets, determining the premium for asset quality and the risk of capital impairment. By analyzing the trend of the market-to-book ratio, an investor assesses the extent to which the market capitalizes the company's intellectual property in affordable home diagnostics and rapid saliva testing relative to the value of its tangible resources.

Direct competitors

Market Value to Book Value Ratio Agilent Technologies A|DGX (questdiagnostics.com) - Market Value to Book Value|Market Value to Book Value Ratio ILMN|Market Cap to Net Assets Ratio Exact Sciences Corp|PerkinElmer - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bio-Rad Corp (BIO)|NNNN - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio soterahealth.com SHC|QuidelOrtho Corporation - Market Capitalization to Book Value Ratio|OPK: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio CareDx|Maravai (MRVI) - Capitalization to Book Value Ratio|FLGT (Fulgent Genetics, Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LAB|Market Value to Book Value Ratio Cytek Biosciences (CTKB)|Market Value to Book Value Ratio exagen.com XGN|MDXH: Market Cap to Net Assets Ratio|Lucid Diagnostics, Inc - Market-to-Book Ratio|Market Value to Book Value Ratio PRE (Prenetics Global Ltd)|IMDX - Market Capitalization to Book Value|trinitybiotech.com - Market Capitalization to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|AIMD: Market Value to Book Value Ratio|Market Capitalization to Book Value CODX|Heart Test Laboratories - Market Value to Book Value Ratio|Market-to-Book Ratio BMRA (biomerica.com)|Market Value to Book Value Ratio Cardio Diagnostics Holdings|Market Value to Book Value Virax Biolabs Group Limited VRAX|Bluejay - Market Capitalization to Book Value Ratio|AWH: Market Capitalization to Book Value Ratio|Accelerate Diagnostics - Market Value to Book Value Ratio|Market Capitalization to Book Value CENTOGENE|ENZ (Enzo Biochem Inc.) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio FRES|Genetic Technologies (GENE) - Market Value to Book Value Ratio|Market Value to Book Value 23andMe Inc (ME)|PMD: Market Capitalization to Book Value Ratio